Author: Himanshu Patni
21 November 2022
A common form of cancer is bladder cancer, which develops in the tissues of the bladder. The urothelial cells that line the interior of the bladder are where it often begins. These cells can be found in the ureters and kidneys. Consequently, urothelial carcinoma can develop in the ureters and kidneys. With other items still in the R&D stage, various plants supply bladder cancer detection kits all over the world. For instance, the UroVysion bladder cancer kit from Abbott Laboratories is offered worldwide. This research involves a multicolor FISH technique and multitarget that involves enumerating four denatured, fluorescent, centromeric chromosomes while smearing exfoliated cells in urine.
The Bladder Cancer Detection Kit Market is expected to grow at a steady rate of around 11% during the forecast period (2022-2028) owing to the increasing demand for bladder cancer diagnoses rises as prevalence and fatality rates rise globally. The market for bladder cancer detection kits is growing as a result of increased R&D spending on non-invasive bladder cancer diagnostic devices.
For a detailed analysis of the Global Bladder Cancer Detection Kit Market browse through – https://univdatos.com/report/bladder-cancer-detection-kit-market/
On the basis of product, the market is categorized into blood sample test, urine sample test, and cell sample test. Among these, the blood sample test to hold a significant share in the market in 2020. Blood samples are used to measure certain substances released into the blood by organs and tissues in the body. However, this segment also caters to considerable presence to check the color of urine and its contents, such as sugar, protein, red blood cells, and white blood cells.
Based on end user, the bladder cancer detection kit market has been classified into hospitals & clinics, diagnostic centres, home care, research centers, and others. The hospitals & clinics category is to witness significant CAGR during the forecast period. The improvement in the hospital infrastructure across the globe is causing the bladder cancer detection kit market. In addition, Diagnostic Centre also has a demand for bladder cancer diagnosis, owing to the immediate diagnosis of the patient’s condition and no long queues. Such procedures are economical for diagnostic centers.
Request for a sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=27745
For a better understanding of the market adoption of the Bladder cancer detection kit industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of bladder cancer. Furthermore, the presence of major players in the region and well-established research organizations engaged in product development, the availability of innovative diagnostic products, and the presence of well-established research organizations engaged in product development all contribute to the bladder cancer detection kit market’s growth.
Some of the major players operating in the market include Cepheid, BIOSYNEX SA, Abbott Laboratories, EXACT Sciences Corporation, Abingdon Health PLC, Xiamen Biotime Biotechnology Co., Ltd., IDL Biotech AB, Alfa Scientific Designs, Biomerica Inc, Hologic Inc.
Global Bladder Cancer Detection Kit Market Segmentation
Market Insight, by Technology
• Fluorescence In Situ Hybridization (FISH)
• Enzyme-Linked Immunosorbent Assay (ELISA)• Others
Market Insight, by Type
Market Insight, by End User
• Hospitals & Clinics
• Diagnostic Centre• Home Care• Research centers• Others
Market Insight, by Region
Top Company Profiles
Get a call back
